Clinical Trial Update: Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Bria-IMT Regimen and a checkpoint inhibitor versus physician's choice in advanced metastatic breast cancer is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Bria-IMT Regimen
• Immune checkpoint inhibitor

Snippet

Sponsor: BriaCell Therapeutics Corporation | Conditions: Breast Cancer, Metastatic Breast Cancer | Phase 3 | Status: RECRUITING